Biofrontera (BFRI) Other Operating Expenses (2020 - 2025)

Biofrontera's Other Operating Expenses history runs 6 years deep, the most recent figure standing at -$9.4 million for Q4 2025.

• On a quarterly basis, Other Operating Expenses fell 278.54% year-over-year to -$9.4 million in Q4 2025; TTM through Dec 2025 was $7.5 million, a 77.31% decrease from a year earlier, with the FY2025 full-year figure at $11.6 million, down 37.89% from the prior year.
• Other Operating Expenses eased to -$9.4 million in Q4 2025 per BFRI's latest filing, from $6.9 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $9.5 million in Q3 2024 and bottomed at -$9.4 million in Q4 2025.
• The 5-year median for Other Operating Expenses is $4.1 million (2021), against an average of $3.7 million.
• Across the five-year window, Other Operating Expenses surged 2381.63% in 2023 and slumped 278.54% in 2025, its largest moves.
• Year by year, Other Operating Expenses stood at $1.8 million in 2021, then jumped by 206.86% to $5.7 million in 2022, then slumped by 168.13% to -$3.9 million in 2023, then soared by 236.61% to $5.3 million in 2024, then slumped by 278.54% to -$9.4 million in 2025.
• Per Business Quant, the three latest BFRI Other Operating Expenses figures stand at -$9.4 million (Q4 2025), $6.9 million (Q3 2025), and $6.8 million (Q2 2025).